36 year old man presenting with pancreatitis and a history of recent commencement of orlistat case report

BACKGROUND: Orlistat is an anti-obesity drug licensed in the United Kingdom for 7 years. We present a case of a patient who developed pancreatitis four days after commencing orlistat. CASE PRESENTATION: A 36 year old man presented to hospital with acute severe pancreatitis four days after starting a...

Descripción completa

Detalles Bibliográficos
Autores principales: Napier, Sarah, Thomas, Matthew
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1560153/
https://www.ncbi.nlm.nih.gov/pubmed/16938137
http://dx.doi.org/10.1186/1475-2891-5-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1560153/
https://www.ncbi.nlm.nih.gov/pubmed/16938137
http://dx.doi.org/10.1186/1475-2891-5-19

Ejemplares similares